Bevacizumab (BV) in combination with folfoxiri (irinotecan, oxaliplatin and infusional 5FU/LV) in metastatic colorectal cancer (MCRC): updates results of a phase II G.O.N.O. trial

Autor:	Vasile, E., GIANLUCA MASI, Loupakis, F., Salvatore, L., Fornaro, L., Cupini, S., Di Marsico, R., Antonuzzo, A., Baldi, G. G., Stasi, I., Pfanner, E., Ciarlo, A., Del Monte, F., Conte, D., Iacovelli, R., Sonaglio, C., Granetto, C., Donati, S., Andreuccetti, M., Alfredo Falcone
Jazyk:	angličtina
Rok vydání:	2009
Zdroj:	Università di Pisa-IRIS
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cb5a1c8e8f509d02e92105e4b9cd7fd9 http://hdl.handle.net/11568/134058 Zobrazit plný text záznamu